Login / Signup

Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma.

Sara V TornbergHarry NisenPetrus JärvinenRiikka JärvinenTuomas P KilpeläinenKimmo TaariUlf-Håkan StenmanHarri Visapää
Published in: Scandinavian journal of urology (2020)
Our data suggest that elevated postoperative S-TATI may be associated with adverse prognosis in RCC patients.
Keyphrases
  • renal cell carcinoma
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • patients undergoing
  • peritoneal dialysis
  • emergency department
  • big data
  • machine learning